Wolverine
Wolverine stack · BPC-157 + TB-500 · healing blend · tissue-repair stack
ANECDOTAL · COMBINATION PEPTIDE STACK
▓ 1 indexed citations across EuropePMC (1).
Citation breakdown by evidence tier
← weaker evidence · stronger evidence →
Tap any tier to jump to that section of the bibliography.
Mechanism of action
Combined cytoprotective + actin regulation (see individual entries)
Researched effects
Synergistic tissue repair; faster recovery (anecdotal)
Live evidence
Live signals refreshed daily. Current as of November 19, 2026.
Dosing reported in literature
BPC 250-500 mcg + TB 2 mg SC daily or split weekly
Known concerns
Combined risk profile of both; no combination safety trials
Full citation library
Year distribution
No references match — clear filters.
Preprints (not yet peer-reviewed)
1-
1.
Body Protection Compound-157 (BPC-157) is an unapproved synthetic peptide marketed directly to consumers despite limited human evidence on benefits and risks. We characterized the use of BPC-157 and patient-reported outcomes from 2020 through 2026 using Large Language Model (LLM) curation of de-identified clinical notes from a U.S. federated network with physician validation of each LLM-curation exercise. Of 1,536 patients with a note mentioning BPC-157, 1,039 (67.6%) had documented use, and qua…
Curated sources on file
3- 1.
- 2.
-
3.
Note: This is a combination/stack entry. No independent indexed primary literature exists for the BPC-157 + TB-500 combination; cited papers describe each component separately.